Preparation & Measurement Guide
MOTS-C 40mg Dosage Protocol
Preparation, measurement, commonly documented protocol ranges, and storage for a MOTS-C 40mg vial.
1. Preparation and Measurement
MOTS-C 40mg With 2mL of Diluent
Add 2mL of bacteriostatic water to the vial. The resulting concentration is 20mg/mL. On a U-100 syringe, each unit contains 200mcg.
Preparation
- Draw 2mL of bacteriostatic water using sterile equipment.
- Let the liquid run slowly down the inside wall of the vial.
- Gently swirl until dissolved. Do not shake.
- Label with the preparation date and refrigerate.
Check the calculation with the peptide calculator.
2. Commonly Documented Schedule
Route commonly described: subcutaneous in circulated protocols. Frequency: once daily.
| Period | Documented amount | Measurement |
|---|---|---|
| Weeks 1-2 | 200mcg once daily | 0.01mL / 1 units |
| Weeks 3-4 | 400mcg once daily | 0.02mL / 2 units |
| Weeks 5-6 | 600mcg once daily | 0.03mL / 3 units |
| Weeks 7-8 | 800mcg once daily | 0.04mL / 4 units |
| Weeks 9-12 | 1mg once daily | 0.05mL / 5 units |
Vial estimate: One 40mg vial contains approximately 200 administrations at the first listed amount or 40 at the final listed amount.
Practical Notes
- The table applies only to this vial prepared with exactly 2mL.
- Some entries are very small measurements; account for the accuracy of the measuring device.
- Record the amount, date, and preparation used.
3. Supplies Needed
- MOTS-C 40mg vial.
- 2mL of bacteriostatic water per vial.
- Sterile U-100 syringes.
- Alcohol swabs.
- Sharps container.
4. Storage and Handling
- Keep unopened vials cool, dry, dark, and protected from moisture.
- After preparation, refrigerate at 2-8 degrees C.
- Protect from light and avoid repeated freeze-thaw cycles.
- Do not use material with particles, discoloration, or a damaged seal.
5. Research Context
MOTS-c is a mitochondrial-derived peptide studied in metabolic regulation, stress responses, and exercise-related signalling. Much of the evidence is preclinical, with limited observational human research.
MOTS-c is not an approved therapeutic drug, and no clinically validated human schedule has been established.